Redhill Biopharma (RDHL) Stock: Buy, Sell, or Hold?
RDHL - Redhill Biopharma Ltd.
$0.50
0.02 (4.17%)
▲
5d:
+0.0%
30d:
-32.52%
90d:
-36.71%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Apr 09, 2026
0d
Get Alerted When RDHL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RDHL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RDHL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RDHL is currently trading at $0.50, which is considered oversold relative to its 30-day fair value range of $0.50 to $0.72.
Technical Outlook: Technically, RDHL is in a strong downtrend. Immediate support is located at $0.46, while resistance sits at $0.57. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: RDHL scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $19000.00 (+3799900.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RDHL is in a strong downtrend. Immediate support is located at $0.46, while resistance sits at $0.57. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: RDHL scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $19000.00 (+3799900.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.50 -
$0.72
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.2%)
- BULLISH: Trading 3799900.0% below Wall St target ($19000.00)
- CAUTION: Bottoming setup, but lagging the sector by 44% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$0.50 -
$0.72
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.46
Resistance Level
$0.57
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1428.57
Wall Street Target
$19000.00
(+3799900.0%)
Revenue Growth (YoY)
58.6%
Share & Embed Analysis
Last updated: October 04, 2026 2:47 AM ET
Data refreshes hourly during market hours. Next update: 3:47 AM
Data refreshes hourly during market hours. Next update: 3:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RDHL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$208 | 62 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$96 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$108 | 56 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 67 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 47 HOLD |
